Info: Read More
  • 中药标准品生产商,产品定制服务
  • 橙黄决明素

    Aurantio-obtusin

    橙黄决明素
    产品编号 CFN99732
    CAS编号 67979-25-3
    分子式 = 分子量 C17H14O7 = 330.29
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Anthraquinones
    植物来源 The seeds of Cassia obtusifolia L.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    橙黄决明素 CFN99732 67979-25-3 10mg QQ客服:2159513211
    橙黄决明素 CFN99732 67979-25-3 20mg QQ客服:2159513211
    橙黄决明素 CFN99732 67979-25-3 50mg QQ客服:2159513211
    橙黄决明素 CFN99732 67979-25-3 100mg QQ客服:2159513211
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • Complutense University of Madrid (Spain)
  • Universidad de Buenos Aires (Argentina)
  • University of Illinois (USA)
  • University of Liège (Belgium)
  • University of Maryland (USA)
  • University of Madras (India)
  • Chiang Mai University (Thailand)
  • Anna University (India)
  • University of Parma (Italy)
  • Universidad de Antioquia (Colombia)
  • University of South Australia (Australia)
  • Heinrich-Heine-University Düsseldorf (Germany)
  • University of Queensland (Australia)
  • University of Vigo (Spain)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • The Japan Society for Analytical Chemistry2017, 613-617
  • Evid-Based Compl Alt2020, 7202519:13
  • Evid Based Complement Alternat Med.2022, 2022:3483511
  • Appl. Sci.2020, 10(8),2804
  • PLoS One.2021, 16(6):e0248479.
  • Int J Cosmet Sci.2019, 41(1):12-20
  • Industrial Crops and Products2022, 186:115298
  • Oxid Med Cell Longev.2022, 2022:5888636.
  • Biochem Biophys Res Commun.2018, 505(1):194-200
  • Biol Pharm Bull.2020, 43(10):1534-1541.
  • Biomed Chromatogr.2019, 8:e4774
  • Metabolites.2023, 13(6):689.
  • J Adv Res.2021, 35:245-257.
  • Evid Based Complement Alternat Med.2022, 2022:1307173.
  • Int J Mol Sci.2017, 19(1)
  • Int J Mol Sci.2021, 22(10):5181.
  • Nutrients.2018, 10(10)
  • Mol Neurobiol.2021, 58(8):3665-3676.
  • Molecules.2019, 24(6):E1177
  • Cells.2021, 10(11):2919.
  • Nutrients.2020, 12(12):3607.
  • Asian Pac J Cancer Prev.2019, 20(1):65-72
  • Int J Mol Sci.2020, 21(9):3239.
  • ...
  • 生物活性
    Description: Aurantio-obtusin possesses anti-allergic, vasorelaxation, hypotensive and hypolipidemic effects, it is a promising osteoanabolic compound with potential therapeutic applications in the prevention of osteoporosis and other metabolic bone diseases. Aurantio-obtusin can inhibit allergic responses in IgE-mediated mast cells and anaphylactic models, it suppresses degranulation, histamine production, and reactive oxygen species generation and inhibits the production and mRNA expression of tumor necrosis factor-α and interleukin-4, and also suppresses the prostaglandin E2 production and expression of cyclooxygenase 2.
    Targets: TNF-α | NO | Akt | NOS | PI3K | Serine | COX | ROS | PGE | IL Receptor
    In vitro:
    J Agric Food Chem. 2015 Oct 21;63(41):9037-46.
    Cassia tora Seed Extract and Its Active Compound Aurantio-obtusin Inhibit Allergic Responses in IgE-Mediated Mast Cells and Anaphylactic Models.[Pubmed: 26434611 ]
    Cassia tora seed is widely used due to its various biological properties including anticancer, antidiabetic, and anti-inflammatory effects. However, there has been no report of the effects of C. tora seed extract (CTE) on immunoglobulin E (IgE)-mediated allergic responses.
    METHODS AND RESULTS:
    In this research, we demonstrated the effects of CTE and its active compound aurantio-obtusin on IgE-sensitized allergic reactions in mast cells and passive cutaneous anaphylaxis (PCA). CTE and aurantio-obtusin suppressed degranulation, histamine production, and reactive oxygen species generation and inhibited the production and mRNA expression of tumor necrosis factor-α and interleukin-4. CTE and aurantio-obtusin also suppressed the prostaglandin E2 production and expression of cyclooxygenase 2. Furthermore, CTE and aurantio-obtusin suppressed IgE-mediated FcεRI signaling such as phosphorylation of Syk, protein kinase Cμ, phospholipase Cγ, and extracellular signal-regulated kinases. CTE and aurantio-obtusin blocked mast cell-dependent PCA in IgE-mediated mice.
    CONCLUSIONS:
    These results suggest that CTE and aurantio-obtusin are a beneficial treatment for allergy-related diseases.
    Planta Med. 2014 May;80(7):544-9.
    Aurantio-obtusin stimulates chemotactic migration and differentiation of MC3T3-E1 osteoblast cells.[Pubmed: 24841966]
    Osteoporosis is one of the major metabolic bone diseases and is among the most challenging noncommunicable diseases to treat. Although there is an increasing interest in identifying bioactive molecules for the prevention and management of osteoporosis, such studies principally focus only on differentiation and mineralization of osteoblasts or inhibition of osteoclast activity. Stimulation of osteoblast migration must be a promising osteoanabolic strategy for improved metabolic bone disease therapy.
    METHODS AND RESULTS:
    In this study, we show that an anthraquinone derivative, Aurantio-obtusin, stimulated chemotactic migration of MC3T3-E1 osteoblast cells in a concentration-dependent manner. The use of a real-time chemotaxis analyzing system, TAXIScan, facilitated the evaluation of both velocity and directionality of osteoblast migration in response to the compound. Besides migration, the compound stimulated osteoblast differentiation and mineralization.
    CONCLUSIONS:
    Taken together, the data presented in this paper demonstrate that Aurantio-obtusin is a promising osteoanabolic compound of natural origin with potential therapeutic applications in the prevention of osteoporosis and other metabolic bone diseases.
    2018 Nov 27;23(12):3093.
    Anti-Inflammatory Effects of Aurantio-Obtusin from Seed of Cassia obtusifolia L. through Modulation of the NF-κB Pathway[Pubmed: 30486383]
    Abstract Aurantio-obtusin, an anthraquinone compound, isolated from dried seeds of Cassia obtusifolia L. (syn. Senna obtusifolia; Fabaceae) and Cassia tora L. (syn. Senna tora). Although the biological activities of Semen Cassiae have been reported, the anti-inflammatory mechanism of aurantio-obtusin, its main compound, on RAW264.7 cells, remained unknown. We investigated the anti-inflammatory effect of aurantio-obtusin on lipopolysaccharide- (LPS)-induced RAW264.7 cells in vitro and elucidated the possible underlying molecular mechanisms. Nitric oxide production (NO) and prostaglandin E₂ (PGE₂) were measured by the Griess colorimetric method and enzyme-linked immunosorbent assay (ELISA), respectively. Protein expression levels of cyclooxygenase 2 (COX-2) were monitored by cell-based ELISA. Interleukin 6 (IL-6) and tumor necrosis factor-alpha (TNF-α) synthesis were analyzed using ELISA. The mRNA expression of nitric oxide synthase (iNOS), COX-2, and the critical pro-inflammatory cytokines (IL-6 and TNF-α) were detected by quantitative real-time PCR. Aurantio-obtusin significantly decreased the production of NO, PGE₂, and inhibited the protein expression of COX-2, TNF-α and IL-6, which were similar to those gene expression of iNOS, COX-2, TNF-α and IL-6 (p < 0.01). Consistent with the pro-inflammatory gene expression, the Aurantio-obtusin efficiently reduced the LPS-induced activation of nuclear factor-κB in RAW264.7 cells. These results suggested that aurantio-obtusin may function as a therapeutic agent and can be considered in the further development of treatments for a variety of inflammatory diseases. Further studies may provide scientific evidence for the use of aurantio-obstusin as a new therapeutic agent for inflammation-related diseases.
    In vivo:
    Journal of Analytical Science,2016, 32(2):178-82.
    Metabolomics-based Study of the Lipid Regulating Effect of Aurantio-obtusin on Hyperlipidemia Rats.[Reference: WebLink]
    The influences of Aurantio-obtusin on endogenous metabolites in blood of hyperlipemia rats were investigated by metabonomics method in order to find the related biomarkers.
    METHODS AND RESULTS:
    The rat model was established by hyperlipidemia rats that were raised by high fat diet and then treated with intragastric administration of Aurantio-obtusin.Metabolites in plasma of hyperlipidemia rats were accurately analyzed by gas chromatography-mass spectrometry.In order to find out the potential biomarkers,principal component analysis,partial least squares discriminant analysis and random forest algorithm were used to study the changes of endogenous metabolite profiles in rats before modeling after modeling and after drug treatments.Ten potential biomarkers were obtained as the final achievement:alanine,glycine,valine,isoleucine,fumaric acid,serine,1,5-anhydro-D-ghlcitol,linoleic acid,stearic acid and cholesterol.
    CONCLUSIONS:
    This investigation demonstrates that aurantio has a good lipid regulating effect mainly by affecting the body amino acid and fatty acid metabolism.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 3.0276 mL 15.1382 mL 30.2764 mL 60.5528 mL 75.6911 mL
    5 mM 0.6055 mL 3.0276 mL 6.0553 mL 12.1106 mL 15.1382 mL
    10 mM 0.3028 mL 1.5138 mL 3.0276 mL 6.0553 mL 7.5691 mL
    50 mM 0.0606 mL 0.3028 mL 0.6055 mL 1.2111 mL 1.5138 mL
    100 mM 0.0303 mL 0.1514 mL 0.3028 mL 0.6055 mL 0.7569 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    2-羟基-1,5-二甲氧基-6-(甲氧基甲基)-9,10- 蒽二酮; 1,5,15-Tri-O-methylmorindol CFN97518 942609-65-6 C18H16O6 = 328.3 5mg QQ客服:1413575084
    橙黄决明素; Aurantio-obtusin CFN99732 67979-25-3 C17H14O7 = 330.29 20mg QQ客服:215959384
    决明素; Obtusin CFN93032 70588-05-5 C18H16O7 = 344.31 5mg QQ客服:3257982914
    黄决明素; Chrysoobtusin CFN91661 70588-06-6 C19H18O7 = 358.34 5mg QQ客服:2056216494
    1,3,6,8-四羟基-2-(1-羟基己基)-蒽醌 ; Averantin CFN96721 5803-62-3 C20H20O7 = 372.37 5mg QQ客服:3257982914
    大黄素; Emodin CFN98834 518-82-1 C15H10O5 = 270.2 20mg QQ客服:2159513211
    1-O-Methylnataloe-emodin; 1-O-Methylnataloe-emodin CFN96731 103392-51-4 C16H12O5 = 284.26 5mg QQ客服:2159513211
    大黄素甲醚; Physcion CFN98848 521-61-9 C16H12O5 = 284.3 20mg QQ客服:215959384
    迷人醇; Fallacinol CFN91577 569-05-1 C16H12O6 = 300.3 5mg QQ客服:3257982914
    1,6-二羟基-8-甲氧基-3-甲基蒽-9,10-二酮; Questin CFN89155 3774-64-9 C16H12O5 = 284.26 5mg QQ客服:1413575084

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产